TAK-243

Near Add Your Location

Sorting 1 by

Accepting patients

TAK-243

A Phase 1 Study of TAK-243 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts
  • Phase 1